Target product profile for the development of pediatric formulations of new drugs for the treatment of children with T. cruzi infection
The TPP provides guidance for essential and ideal characteristics of formulations of new drugs for the treatment of children with T. cruzi infection.
Authors
- Ana Cristina Pereiro (ORCID: https://orcid.org/0000-0002-5207-0284)
- Jaime Altcheh (ORCID: https://orcid.org/0000-0002-5865-7991)
- Andrea Marchiol (ORCID: https://orcid.org/0000-0001-6118-1931)
- Javier Sancho (ORCID: https://orcid.org/0000-0002-2879-9200)
- Samanta Moroni (ORCID: https://orcid.org/0000-0003-4034-2876)
- Rafael Herazo
- Sandra Seu
- Freddy Tinajeros
- Pinazo María-Jesús (ORCID: https://orcid.org/0000-0002-4237-1075)
- Tayná Marques
- Elvira-Idalia Hernández Cuevas
- Guillermo Moscatelli
- Facundo Garcia-Bournissen
- Lourdes Ortiz-Daza
- Colin Forsyth
Institutions
- Universitat de València (ES)
- Instituto de Salud Carlos III (ES)
- National University of Santiago del Estero (AR)
- Prisma (PE)
- Centro de Investigación Biomédica en Red (ES)
- Fundación Pro Salud y Medio Ambiente (AR)
- Universidad Autónoma Juan Misael Saracho (BO)
- Ministerio de Salud (BO)
- Fundação Carlos Chagas (BR)
- Hospital General de Niños Ricardo Gutierrez (AR)
Publication Details
- Journal
- PLoS neglected tropical diseases
- Published
- 2026-01-09
- DOI
- https://doi.org/10.1371/journal.pntd.0013597
- Primary Topic
- Trypanosoma species research and implications
- Type
- article
- Field-Weighted Citation Impact
- 0.00